Hemodynamic Monitoring by FloTrac Sensor in Patients with Acute Congestive Heart Failure

Hemodynamic Monitoring by FloTrac Sensor in Patients with Acute Congestive Heart Failure - Hemodynamic Monitoring by FloTrac Sensor in Patients with ACHF

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019312

Enrollment

Registered

2015-10-14

Start date

2015-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Congestive Heart Failure

Interventions

To utilize FroTrac Sensor for hemodynamic monitoring.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute congestive heart failure who admitted to the coronary care unit.

Exclusion criteria

Exclusion criteria: Patients with acute coronary syndrome Patients treated with intra abdominal balloon pump or extracorporeal membrane oxygenation Patients with severe aortic valve regurgitation Patients with atrial fibrilation or flutter Patients who refused enrollment

Design outcomes

Primary

Measure	Time frame
The correlation between hemodynamic data calculated by FloTrac Sensor (cardiac out put, peripheral vascular resistance, and stroke volume variation) and physical findings, and the correlation between hemodynamic data calculated by FloTrac Sensor and those data calculated by echocardiography.	—

Secondary

Measure	Time frame
Short term outcome: in-hospital death, acute renal failure, length of CCU stay, and length of hospital stay. Long term outcome: left ventricular end systolic volume index and brain natriuretic peptide level at 12 months.	—

Countries

Japan

Contacts

Public ContactYu Horiuchi

Mitsui Memorial Hospital Division of Cardiology

yooouyou@gmail.com0338629111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026